Halozyme Therapeutics | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 762M 80.42M 2025-06
Agios Pharmaceuticals USD 80.87M 1.91M 2025-06
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Amarin USD 119.52M 1.51M 2025-03
Amgen USD 8.03B 782M 2025-06
Baxter International USD 2.29B 530M 2025-03
Cytokinetics USD 74.94M 863.28M 2025-06
DBV Technologies USD 0 0 2025-03
Eli Lilly USD 3.38B 282.6M 2025-06
Halozyme Therapeutics USD 61.86M 114.47M 2025-06
Ionis Pharmaceuticals USD 297.3M 33.11M 2025-06
MannKind USD 57.01M 9.69M 2025-06
Pfizer USD 1.64B 208M 2025-06
United Therapeutics USD 1.59B 306.8M 2025-06


Halozyme Therapeutics Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.